Walmsley Under Pressure Over GSK’s Strategy

Activist Investor Preparing To Pounce

GSK HQ
Investors remain unimpressed with GSK's turnaround efforts - but support for Elliott's rebellion is likely to be limited.

More from Business

More from Scrip